Jeffrey Miller, MD
Enriched profileDirector, Masonic Cancer Center; Professor of Medicine, Division of Hematology, Oncology and Transplantation; Roger L. and Lynn C. Headrick Chair in Cancer Therapeutics · University of Minnesota Medical School
Jeffrey Miller is Director, Masonic Cancer Center; Professor of Medicine, Division of Hematology, Oncology and Transplantation; Roger L. and Lynn C. Headrick Chair in Cancer Therapeutics at University of Minnesota Medical School. OpenAlex indexes 1,174 publications with 47,488 citations (h-index 113); ClinicalTrials.gov lists 27 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Jeffrey S. Miller, MD, is Director, Masonic Cancer Center at University of Minnesota Medical School / Masonic Cancer Center. The public record shows 1,174 publications with 47,488 citations (h-index 113), centered on Hematology. It also documents an investigator role on 27 registered clinical trials, industry payments reported by 7 companies, 12 NIH-funded awards (1991–2026).
- Most recent indexed publication: 2026 · Clinical infectious diseases
- Top research focus: Hematology
- 27 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 31 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 27 registered studies on ClinicalTrials.gov. The most recent:
- Pattern Separation in Major Depressive Disorder
Sponsor: Jeffrey Miller
- Anti-suicidal Effects of Buprenorphine In Depressed Individuals
Sponsor: New York State Psychiatric Institute
Industry payments
Updated 27 Aug 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20253 payments
- GENZYME CORPORATIONProgram year202310 payments$13,394openpaymentsdata.cms.gov ↗
- Regeneron Pharmaceuticals, Inc.Program year202312 payments$10,017openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Corticosteroid100%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
12 NIH research awards on record, funded 1991–2026 per NIH RePORTER. The latest:
- Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors
University of Minnesota
FY2026$928,524R35CA283892 - Synaptic and glutamatergicalterations in mood disorders andsuicide behavior
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
FY2026$695,612P50MH139573
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.
Clinical infectious diseases
Article2026 - Reprogramming endogenous NK circuits by highly efficient nonviral genome editing.
The Journal of experimental medicine
Article2026 - Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid Tumors.
Cancer immunology research
Article2026 - A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer.
Cancer immunology research
Article2025
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jeffrey-miller-md-ebe89637
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
cancer.umn.edu/news/dr-jeffrey-miller-awarded-9m-nih/nci-p01-program-project-grant-develop-shelf-nk-cells
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.umn.edu ↗ - Apple Podcasts
podcasts.apple.com/us/podcast/the-chain-protein-engineering-podcast/id1477483749
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗ - Other
aacr.org/governance/jeffrey-s-miller
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aacr.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mphysicians.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.umn.edu ↗
- BS
Northwestern University (Evanston, IL)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancer.umn.edu ↗ - Internship and Residency in Internal Medicine
University of Iowa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.umn.edu ↗ - Post-doctoral Fellowship in Hematology
Oncology and Transplantation, University of Minnesota
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.umn.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.umn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
- Section Head
Blood and Marrow Transplant (BMT) and Cell Therapy, Division of Hematology, Oncology and Transplantation, UMN
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.umn.edu ↗
- Distinguished Research Lecture Award
University of Minnesota Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗
Secondary affiliations
appointments beyond the home institution- Faculty
Microbiology, Immunology and Cancer Biology (MICaB) PhD Graduate Program, University of Minnesota
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗ - Preceptor
Medical Scientist Training Program (MD/PhD), University of Minnesota
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.umn.edu ↗ - Scientific Advisory Board member
ONK Therapeutics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onktherapeutics.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hebecellcorp.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cgtlive.com ↗
- "Novel Strategies to Produce Better NK Cells for Cancer Treatment" - podcast/keynote transcript
Discovery On Target conference
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →discoveryontarget.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Weisdorf, MD
University of Minnesota Medical School
Emmanuel Antonarakis, MD
University of Minnesota Medical School
David Boulware, MD, MPH
University of Minnesota Medical School
Jerrold Vitek, MD
University of Minnesota Medical School